AIA Group Ltd decreased its stake in shares of Xylem Inc. (NYSE:XYL – Free Report) by 15.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,111 shares of the industrial products company’s stock after selling 394 shares during the period. AIA Group Ltd’s holdings in Xylem were worth $273,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in XYL. Bruce G. Allen Investments LLC acquired a new position in shares of Xylem during the fourth quarter worth approximately $27,000. FinTrust Capital Advisors LLC raised its position in Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 200 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after buying an additional 220 shares in the last quarter. Spire Wealth Management boosted its position in Xylem by 370.9% in the 4th quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock valued at $54,000 after buying an additional 382 shares during the last quarter. Finally, Advantage Trust Co acquired a new stake in shares of Xylem in the 4th quarter valued at $57,000. Institutional investors own 87.96% of the company’s stock.
Xylem Stock Performance
XYL stock opened at $138.42 on Friday. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $146.08. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19. The firm has a market cap of $33.56 billion, a PE ratio of 49.26, a P/E/G ratio of 2.46 and a beta of 1.04. The business’s 50-day moving average price is $139.18 and its two-hundred day moving average price is $128.62.
Xylem Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend was Thursday, May 30th. Xylem’s dividend payout ratio (DPR) is presently 51.25%.
Insider Transactions at Xylem
In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, SVP Rodney Aulick sold 21,800 shares of Xylem stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the sale, the senior vice president now directly owns 76,287 shares in the company, valued at $10,604,655.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the sale, the chief accounting officer now directly owns 3,536 shares in the company, valued at approximately $490,195.68. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on XYL shares. Citigroup raised their price target on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Robert W. Baird lifted their price target on shares of Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. Mizuho boosted their price target on shares of Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, May 3rd. Argus raised their price objective on shares of Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 29th. Finally, Oppenheimer upped their target price on shares of Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $142.92.
Read Our Latest Stock Analysis on Xylem
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
- Five stocks we like better than Xylem
- How is Compound Interest Calculated?
- Top 3 Defense Stocks That Should Be on Your Radar
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.